CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION
|
disease |
|
Disease or Syndrome
|
1
|
3
|
0.700 |
None |
1.000 |
2 |
3
|
2012 |
2015 |
Epithelioid hemangioendothelioma
|
disease |
Neoplasms
|
Neoplastic Process
|
36
|
4
|
0.400 |
None |
0.952 |
21 |
|
2011 |
2019 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.110 |
None |
1.000 |
3 |
1
|
2007 |
2011 |
Amyotrophic Lateral Sclerosis, Sporadic
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
173
|
90
|
0.110 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Mild Mental Retardation
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
340
|
56
|
0.110 |
None |
1.000 |
1 |
|
2014 |
2014 |
Global developmental delay
|
disease |
|
Mental or Behavioral Dysfunction
|
1825
|
553
|
0.110 |
None |
1.000 |
1 |
|
2015 |
2015 |
Epithelioid hemangioendothelioma, malignant
|
disease |
Neoplasms
|
Neoplastic Process
|
29
|
|
0.100 |
None |
0.933 |
15 |
|
2011 |
2019 |
Childhood Epithelioid Hemangioendothelioma
|
disease |
Neoplasms
|
Neoplastic Process
|
26
|
|
0.100 |
None |
0.917 |
12 |
|
2011 |
2019 |
Adult Epithelioid Hemangioendothelioma
|
disease |
Neoplasms
|
Neoplastic Process
|
26
|
|
0.100 |
None |
0.917 |
12 |
|
2011 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
10 |
|
2003 |
2019 |
Muscle hypotonia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
967
|
579
|
0.100 |
None |
1.000 |
8 |
1
|
2006 |
2015 |
Dysmorphic features
|
disease |
|
Congenital Abnormality
|
439
|
617
|
0.100 |
None |
1.000 |
8 |
1
|
2006 |
2015 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
Major Depressive Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1236
|
1451
|
0.100 |
None |
1.000 |
2 |
2
|
2018 |
2018 |
AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE
|
disease |
|
Disease or Syndrome
|
31
|
54
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Platelet mean volume determination (procedure)
|
phenotype |
|
Laboratory Procedure
|
223
|
371
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
mathematical ability
|
phenotype |
|
Mental Process
|
854
|
2127
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Fatty acid measurement
|
group |
|
Laboratory Procedure
|
50
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Memory, Episodic
|
phenotype |
|
Mental Process
|
2
|
2
|
0.100 |
None |
1.000 |
1 |
1
|
2007 |
2007 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.100 |
None |
1.000 |
1 |
1
|
2020 |
2020 |
Mood Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
580
|
308
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Duration of sleep
|
phenotype |
|
Finding
|
104
|
203
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
AMYOTROPHIC LATERAL SCLEROSIS 6 (disorder)
|
disease |
|
Disease or Syndrome
|
27
|
67
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |